Aetion, a Datavant Company
Software DevelopmentNew York, United States51-200 Employees
Aetion, based in New York City, develops software that produces real-world evidence about medical treatments and technologies for manufacturers, purchasers, and regulators. Its platform analyzes real-world data to generate findings on safety, effectiveness, and value that are intended to be transparent, rapid, and scientifically validated. The company was founded by Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, and it aims to illuminate which treatments work best, for whom, and when, to guide product development, commercialization, and payment approaches. Aetion operates in the software development industry and is now a Datavant company, following a May 2025 acquisition designed to expand life sciences capabilities and link clinical trial data with real-world data. A recent development highlighted in the news is the launch of Aetion Activate, reflecting ongoing product expansion and improved accessibility of its platform.